Document is current
Any future updates will be listed below
-
Authors
Sakboonyarat, Boonsub
Poovieng, Jaturon
Jongcherdchootrakul, Kanlaya
Srisawat, Phutsapong
Hatthachote, Panadda
Mungthin, Mathirut
Rangsin, Ram
-
Funding
Funding for this research was provided by:
The FETP-NCD, Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand (N/A, N/A, N/A)
The Research Unit for Military Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand. (N/A, N/A, N/A)
- License Information
-
More Information
Article History
Received: 10 April 2022
Accepted: 10 August 2022
First Online: 17 August 2022
Declarations
:
: The study was reviewed and approved by the Institutional Review Board, Royal Thai Army Medical Department in compliance with international guidelines such as the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use - Good Clinical Practice (ICH - GCP) (approval number S067h/64). Due to using secondary data, a waiver of documentation of informed consent was used. The Institutional Review Board, Royal Thai Army Medical Department approved informed consent waiver.
: Consent for publication is not applicable.
: The authors declare they have no competing interests.
